Skip to main content
. 2013 Apr 12;32(11):1529–1542. doi: 10.1038/emboj.2013.75

Figure 5.

Figure 5

GCYs modulate lifespan independently of DAF-2/DAF-16 or DAF-12 signalling. (A–D) Survival curves of N2 wildtype (WT) strain versus gcy-31(ok296) (A), gcy-33(ok232) (B), gcy-35(ok769) (C) or gcy-36(db66) (D) mutants treated with daf-2(RNAi), daf-16(RNAi) or control RNAi (Con). All experiments in (A–D) were performed at the same time, and the same groups of WT (Con), daf-2(RNAi), and daf-16(RNAi) were compared to individual gcy mutants. (E–H) Survival curves of N2 WT strain versus gcy-31(ok296) (E), gcy-33(ok232) (F), gcy-35(ok769) (G), or gcy-36(db66) (H) mutants treated with daf-12(RNAi) or control RNAi (Con). All experiments in (E–H) were performed at the same time, and the same groups of WT (Con) and daf-12(RNAi) were compared to individual gcy mutants. Statistics for curve comparisons are shown in the figure, n=24–45 per group (A–D), n=25–43 per group (E–H). Mean lifespan and 75th percentile lifespan of (A–D) are shown in Supplementary Figure S3, and mean lifespan and 75th percentile lifespan of (E–H) are shown in Supplementary Figure S4.